Purchase Order 75N93024P00184
Award Date 3/29/24
Potential Completion Date 12/31/24
Potential Value $44K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Carlsbad, CA 92008, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
4
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation for $24,840.00 on September 15, 2017, for EXPI293 Expression Medium 1000 (catalog #A1435101), completing August 19, 2018. Performance occurs in Carlsbad, California. This is a firm fixed price purchase order for a commercial laboratory consumable with no set-aside designation.</p>
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $106,018.00 contract is for the purchase of EXPI293 expression medium over 6 scheduled shipment dates. The award does not utilize a set-aside. Life Technologies serves as a prime contractor to NIAID and other federal agencies, providing a range of...
- Life Technologies Corporation, a subsidiary of Thermo Electron Corporation Financial Services Division, has been awarded a $14,781 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide expression medium. The place of performance will be Life Technologies' facility in Carlsbad, California. The one-year contract runs from August 2023 through August 2024 to support NIH's research into allergies and infectious...
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $19,380.00 firm fixed price purchase order is for EXPI293 Expression Medium and ExpiFectamine 293 Transfection Kit products, which support biomedical research. Life Technologies is a division of the parent company...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $63,396.00 firm fixed-price purchase order to Life Technologies Corporation, doing business as Thermo Fisher Scientific, for the procurement of Freestyle 293 Expression Medium and EXPI293 Expression Medium. These specialized cell culture media products are critical for protein and antibody production in vaccine development research targeting HIV-1, SARS-CoV-2, and other viruses at the NIAID Vaccine Research Center. The...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order contract to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract, valued at $113,690.02, is for the provision of biologicals and mediums, with a completion date of March 7, 2022. Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, has a history of...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $16,252.20 firm fixed price purchase order to Life Technologies Corporation for tissue culture reagents under a standing order with multiple deliveries (AMBIS #2185979). Performance will occur in Carlsbad, California over a one year period ending September 2024. As a leading supplier of biotechnology products and services, Life Technologies Corporation, a...
- Life Technologies Corporation, a subsidiary of Thermo Electron Corporation Financial Services Division, has been awarded a $45,220 firm fixed price purchase order by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health within the Department of Health and Human Services. The contract calls for the delivery of FREESTYLE 293 EXPRESSION MEDIA, EXPI293 EXPRESSION MEDIUM 6 X 1L AND HT SUPPLEMENT to the prime contractor's facility in Grand...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $18,225 purchase order to Life Technologies Corporation for EXPIFECTAMINE transfection reagent kits. The fixed-price contract runs from August 31, 2023 through November 30, 2023 for delivery of the 10-liter kits to a facility in Grand Island, New York. Life Technologies Corporation, a subsidiary of Thermo Electron Corporation Financial Services Division,...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation valued at $49,500 on August 15, 2017, with completion by September 14, 2017. Performance occurs in Carlsbad, California. The order is firm fixed price with no small business set-aside. The specific requirements and line items are not detailed in the source documentation.</p>
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $43,616 firm fixed price purchase order to Life Technologies Corporation. Under this contract, Life Technologies will provide 32 units of EXPI 293 Expression Media to the agency in five shipments for use in its research programs. Performance will occur in Carlsbad, California and last through the end of calendar year 2024. No set aside designation or subcontractors were identified. This award will support the NIH's efforts to advance understanding of diseases such as allergies and infectious conditions through expression media for its laboratories.
Generated 12/28/23, 10:12 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.6k | 12/27/23 |